Standard vs. Telemedicine Surveillance for Head and Neck Cancer

This trial aims to determine which follow-up method is better for individuals with HPV-related head and neck cancer who show no signs of the disease after treatment. It compares traditional in-person check-ups, known as standard surveillance, with telemedicine, where patients connect with their healthcare team through video calls or phone from home. The study examines how each approach affects quality of life, health outcomes, costs, and satisfaction levels among doctors and patients. Individuals who recently completed treatment for HPV-associated cancer and show no evidence of disease may be suitable candidates for this trial. As an unphased trial, it offers a unique opportunity to contribute to research that could enhance future care options.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Research shows that telemedicine is generally safe for patients with head and neck cancer. Studies have found that patients using telemedicine feel more in control of their health and can reduce clinic visits. This approach allows patients to stay at home while maintaining regular check-ins with their doctors through video or phone calls.

Researchers are excited about the trial comparing telemedicine surveillance to standard care for head and neck cancer because it could revolutionize how patients are monitored after treatment. Unlike traditional follow-up, which requires in-person visits and procedures at a clinic, telemedicine allows patients to stay at home and still receive comprehensive care through video conferencing and phone calls. This approach could make cancer surveillance more convenient and accessible, especially for those who live far from healthcare facilities or have mobility issues. By potentially reducing the need for frequent clinic visits, telemedicine might also help lower healthcare costs and improve patients' quality of life.

This trial will compare standard surveillance with telemedicine surveillance (tele-surveillance) for head and neck cancer. Research has shown that telemedicine benefits patients with head and neck cancer. Studies indicate that tele-surveillance increases patients' sense of control and reduces hospital visits. It also enhances health management through remote check-ups and online communication. Both patients and doctors express high satisfaction with telemedicine, which has been linked to fewer hospital trips. This suggests that tele-surveillance could effectively manage head and neck cancer.¹²³⁶⁷